Objective:

To evaluate the short-term effects on vascular age and other major risk factors of an integrated atherosclerosis risk-guided cardiovascular prevention program.

Methods:

A quasi-experimental intervention study was conducted between the years 2013 to 2015 on 190 patients with multiple comorbidities and two or more cardiovascular risk factors. Of the cases analysed, the 177 patients that had multiple risk factors or metabolic síndrome entered the integrated atherosclerosis clinical stratification-guided program. The variables measured before and after the intervention during a three months follow-up, included blood pressure, lipid profile, HbA1c, anthropometric measurements, overall 10-year cardiovascular risk, and vascular age.

Results:

Decreases were observed in, the mean systolic blood pressure (6.9 mmHg, 95% CI; 4.6-9.3, P<.001), diastolic blood pressure (2.8 mmHg, 95% CI; 1.3-4.3, P<.001), Total Cholesterol (10.1 mg/dl, 95% CI; 2.5-17.7; P=.010), LDL Cholesterol (9.9 mg/dl, 95% CI; 2.1-17.6; P=.013), and HbA1c (0.4%, 95% CI; 0.2-0.6, P<.001). There was also a reduction in the overall 10-year cardiovascular risk (4.8%, 95% CI; 3.2-6.5, P<.001)), as well as vascular age (1.4 years, 95% CI; 0.6-2.3, P<.001)).

Conclusions:

In the short-term, the integrated atherosclerosis risk-guided cardiovascular prevention program implemented in patients with multiple comorbidities showed a reduction in blood pressure levels, as well as those for Total Cholesterol, LDL Cholesterol, HbA1c, the overall 10-year cardiovascular risk score, and vascular age.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )